Drug Discovery
Singapore's Biosyngen Gets FDA Nod for BRL03 Trials in Advanced Solid Tumors
Notably, BRL03 is also the first TCR-T product developed by Biosyngen to enter clinical trials. This significant achievement is attributed to the...
September 12, 2023 | News
Brii Biosciences Reports Phase 2 Results for BRII-179 in Hepatitis B Combo Treatment
The cohort level unblinded data from the study demonstrated that in the intent to treat analysis at Week 24 (end of treatment or EoT), 26.3% (15 pa...
September 07, 2023 | News
ACM Biolabs Reports Positive Phase I Results for SARS-CoV-2 Booster Vaccine ACM-001
Provides clinical validation for ACM Biolab's Tunable Platform ("ATP™"), ACM Biolab's proprietary polymer-based delivery platform ACM-...
September 06, 2023 | News
"Innovation Down Under: Exploring the Australian BioPharma Industry"
Introduction Nestled on the vast, sunburned continent known for its stunning landscapes and unique wildlife, the Australian BioPharma industry has...
September 05, 2023 | Analysis
ABM Therapeutics Initiates Phase I Study of ABM-1310 in BRAF V600 Brain Tumors
ABM-1310, the company's proprietary clinical candidate developed as a next-generation BRAF inhibitor and demonstrated superior properties in pre-clinical a...
September 04, 2023 | News
South Korea's Genexine's Long-Acting Growth Hormone Meets Phase 3 Endpoint
Phase 3 clinical trial in China meets primary endpoint On track to file BLA in China in 2024 The study being conducted by Genexine’s partner in...
August 31, 2023 | News
Menarini's ELZONRIS® (Tagraxofusp) Receives Orphan Drug Designation for BPDCN by Japanese Ministry of Health
The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-own...
August 31, 2023 | Regulatory
Epigenic Therapeutics Raises $32M for Breakthrough Epigenome Medicine Development
This round of financing will support the preclinical development and early clinical validation of two leading programs, discovery of future pipelines, expa...
August 30, 2023 | News
BOC Sciences Introduces a Novel XDC Bioconjugation Platform to Advance Biomedical Research
The newly developed XDC bioconjugation platform offered by BOC Sciences introduces a range of advanced technologies and optimized protocols, revolutionizin...
August 25, 2023 | News
Sanyou and Sinorda Partner for Innovative Drug Research
According to the cooperation agreement, leveraging Sanyou's world-leading core technology platform for integrated R&D and preclinical development of in...
August 23, 2023 | News
CanariaBio's MAb-AR20.5 for Pancreatic Cancer Granted FDA Orphan Drug Designation
CanariaBio Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative immunotherapies for cancer, anno...
August 22, 2023 | News
Everest Medicines' Partner Calliditas Therapeutics Gets FDA Priority Review for Nefecon® in IgA Nephropathy
"We congratulate our partner Calliditas for being granted priority review by the FDA for full approval and taking a step closer to offering this first-in-d...
August 22, 2023 | Regulatory
Verily and OneOncology Announce Collaboration to Advance Cancer Research
Verily, an Alphabet precision health technology company, and OneOncology, the national platform for independent oncology practices, have established a stra...
August 17, 2023 | News
Daewoong Pharmaceutical Introduces 'Fexuprazan' with Global Export to the Philippines
Daewoong Pharmaceutical (CEO Jeon Seng-ho, Lee Chang-jae) announced that 'Fuxuprazan' is officially launched in the Philippines o...
August 17, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
